On the basis of ER, progesterone receptor (PR), and HER2 presentation, breast cancers are usually divided into three types, namely hormone receptor positive (ER+, PR+, HER2+), HER2 positive (ER−, PR−, HER2+), and triple negative. Here, NR4A1 is linked to breast cancer.